Logo

Interleukin Collaborates with Geisinger Health on Obesity Genetics

Sep 18, 2008
NEW YORK (GenomeWeb News) — Interleukin Genetics will collaborate with Pennsylvania-based Geisinger Health System to study the role of certain genes in obesity, the company said today.
 
The aim of the project is to develop genetic tests that will indicate a patient's inherited
resistance to weight loss "and, more specifically, gauge a patient's likelihood of success with diet and other weight loss techniques," the company said. 

Interleukin Genetics said it will use Geisinger’s health records and medical knowledge of obesity to develop the tests.

 
Geisinger and Interleukin Genetics will conduct a case control retrospective study to analyze variations of perilipin, interleukin 1, and “a select number of other genes,” the company said.
 
Geisinger is comprised of three medical centers, a Center for Health Research, and a non-profit health insurance company.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.